首页> 外文期刊>Antiviral Research >Foot-and-Mouth Disease Virus neutralizing antibodies production induced by pcDNA3 and Sindbis virus based plasmid encoding FMDV P1-2A3C3D in swine.
【24h】

Foot-and-Mouth Disease Virus neutralizing antibodies production induced by pcDNA3 and Sindbis virus based plasmid encoding FMDV P1-2A3C3D in swine.

机译:猪中口蹄疫病毒中和抗体的产生由pcDNA3和基于Sindbis病毒的质粒编码,编码FMDV P1-2A3C3D。

获取原文
获取原文并翻译 | 示例
       

摘要

DNA vaccination against Foot-and-Mouth Disease Virus (FMDV) is an attractive and alternative strategy to the use of classical inactivated viral vaccines. The injection of a pcDNA3.1-based DNA vaccine encoding for FMDV P1-2A3C3D and GM-CSF proteins had previously been shown to induce the production of neutralizing antibodies against FMDV and partially protect swine against an experimental challenge. Based on the induction of FMDV humoral immune responses, the aim of the present study was to see if the Sindbis virus derived plasmid (pSINCP) backbone could advantageously replace pcDNA3.1 in DNA immunization against FMDV in swine. For this purpose, groups of 3 or 4 pigs received three injections by intramuscular route, intradermal route or an association of both routes, at 2-3 week intervals. The pcDNA3.1-based DNA vaccine was shown to induce the production of higher amounts of FMDV-neutralizing antibodies after intradermal injection. Intramuscular injection of the same vaccine, or intramuscular (IM) and/or intradermal (ID) injection of the pSINCP-based DNA vaccine resulted in a significantly lower induction of FMDV-neutralizing antibodies. In conclusion, the humoral immune response of a DNA vaccine encoding for FMDV P1-2A3C3D was not improved by the pSINCP backbone and was higher when the plasmids were injected by the intradermal route.
机译:针对口蹄疫病毒(FMDV)的DNA疫苗接种是使用经典灭活病毒疫苗的一种有吸引力的替代策略。先前已显示注射编码FMDV P1-2A3C3D和GM-CSF蛋白的基于pcDNA3.1的DNA疫苗可诱导产生针对FMDV的中和抗体,并部分保护猪免受实验挑战。基于对FMDV体液免疫反应的诱导,本研究的目的是观察Sindbis病毒衍生质粒(pSINCP)骨架能否在猪针对FMDV的DNA免疫中取代pcDNA3.1。为此,每组3或4头猪以2-3周的间隔通过肌内途径,皮内途径或两种途径的结合进行了3次注射。皮内注射后,基于pcDNA3.1的DNA疫苗可诱导产生更高数量的FMDV中和抗体。肌内注射同一疫苗,或肌内(IM)和/或皮内(ID)注射基于pSINCP的DNA疫苗,导致FMDV中和抗体的诱导明显降低。总之,pSINCP主链不能改善编码FMDV P1-2A3C3D的DNA疫苗的体液免疫应答,而通过皮内途径注射质粒时,体液免疫应答更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号